0001179110-17-000380.txt : 20170104
0001179110-17-000380.hdr.sgml : 20170104
20170104191600
ACCESSION NUMBER: 0001179110-17-000380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161230
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pelossof Avi
CENTRAL INDEX KEY: 0001293460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 17508029
MAIL ADDRESS:
STREET 1: 3661 HORSEBLOCK ROAD
CITY: MEDFORD
STATE: NY
ZIP: 11763
4
1
edgar.xml
FORM 4 -
X0306
4
2016-12-30
0
0001145460
ALERE INC.
ALR
0001293460
Pelossof Avi
51 SAWYER ROAD, SUITE 200
WALTHAM
MA
02453
0
1
0
0
GlobalPres, Infectious Disease
Common Stock
2016-12-30
4
M
0
20000
38.70
A
35524
D
Common Stock
2016-12-30
4
F
0
19903
39
D
15621
D
Common Stock
2016-12-30
4
M
0
9668
38.70
A
25289
D
Common Stock
2016-12-30
4
F
0
9627
38.96
D
15662
D
Common Stock
2016-12-30
4
M
0
10332
38.70
A
25994
D
Common Stock
2016-12-30
4
F
0
10263
38.96
D
15731
D
Employee Stock Option (right to buy)
38.70
2016-12-30
4
M
0
20000
D
2017-01-01
Common Stock
20000
9668
D
Employee Stock Option (right to buy)
38.70
2016-12-30
4
M
0
9668
D
2017-01-01
Common Stock
9668
0
D
Employee Stock Option (right to buy)
38.70
2016-12-30
4
M
0
10332
D
2017-01-01
Common Stock
10332
0
D
These options became exercisable in four equal annual installments beginning January 1, 2007.
This derivative security does not have a price.
Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above.
The Options were scheduled to expire on January 1, 2017.
/s/ Douglas Barry, Attorney-in-Fact
2017-01-04